ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 321.60
+16.60 (5.44%)
May 6, 2026, 4:59 PM CET
ChemoMetec Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 8% year-over-year with strong XM platform adoption and improved margins. Upgraded guidance reflects broad customer interest, with larger XM orders expected by fiscal year-end. Strategic focus is on software and automation, supporting long-term profitability.
Fiscal Year 2025
-
Revenue, EBITDA, and cash flow increased year-over-year, with strong growth across all segments and a high gross margin. Guidance anticipates 10–14% sales growth, margin improvement, and major investments in automation and software, while macro and currency risks remain.